Key Metrics
CiteScore 

2
H-Index 

19
SJR 

Q4Rheumatology

SNIP 

0.53
Recommended pre-submission checks
Powered by 

Egyptian Rheumatologist Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Quarterly |
| Publication Time | 39 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Egyptian Society of Rheumatic Diseases |
| Frequency | Quarterly |
| Publication Start Year | 1977 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Egyptian Rheumatologist ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Egyptian Rheumatologist
Linking inflammatory pathways to nutritional interventions in systemic lupus erythematosus (SLE): Toward a context-specific nutritional framework
- 1 Jun 2026
- The Egyptian Rheumatologist
Role of urinary biomarkers in the diagnosis of lupus cystitis in systemic lupus erythematosus patients: Relation to disease activity and lower urinary tract manifestations
- 1 Apr 2026
- The Egyptian Rheumatologist
Assessment of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus and its association with disease activity, functional status, pain severity and depression
- 1 Apr 2026
- The Egyptian Rheumatologist
Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin
- 1 Apr 2026
- The Egyptian Rheumatologist
Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease
- 1 Apr 2026
- The Egyptian Rheumatologist
The potential role of neutrophil, eosinophil, and platelet to lymphocyte ratios in the assessment of disease activity in systemic lupus erythematosus patients
- 1 Apr 2026
- The Egyptian Rheumatologist
Linking inflammatory pathways to nutritional interventions in systemic lupus erythematosus (SLE): Toward a context-specific nutritional framework
- 1 Jun 2026
- The Egyptian Rheumatologist
Role of urinary biomarkers in the diagnosis of lupus cystitis in systemic lupus erythematosus patients: Relation to disease activity and lower urinary tract manifestations
- 1 Apr 2026
- The Egyptian Rheumatologist
Assessment of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus and its association with disease activity, functional status, pain severity and depression
- 1 Apr 2026
- The Egyptian Rheumatologist
Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin
- 1 Apr 2026
- The Egyptian Rheumatologist
Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease
- 1 Apr 2026
- The Egyptian Rheumatologist
The potential role of neutrophil, eosinophil, and platelet to lymphocyte ratios in the assessment of disease activity in systemic lupus erythematosus patients
- 1 Apr 2026
- The Egyptian Rheumatologist